glp/gip/glucagon & cagrilintide GIPR/GLP-1R dual agonist therapies for diabetes and weight loss—chemistry, physiology, and clinical applications Possible mechanisms of glucagon‐like peptide‐1

Mouriquand PDE, Gorduza DB, Gay C, Meyer-Bahlburg HFL, Baker L, Baskin LS, Bouvattier C, Braga LH, Caldamone AC, Duranteau L, El Ghoneimi A, Hensle TW, Hoebeke P, Kaefer M, Kalfa N, Kolon TF, Manzoni G, Mure P, Nordenskjold A, Pippi Salle JL, Poppas DP, Ransley PG, Rink RC, Rodrigo R, Sann L, Schober J, Sibai H, Wisniewski A, Wolffenbuttel KP, Lee P (2016) Surgery in disorders of sex development (DSD) with a gender issue: If (why), when, and how

However, as projects transition toward advanced translational applications, the inherent stochasticity of physical entrapment and the strict 3 kb thermodynamic limit for cargo size often necessitate a shift toward more programmable, sequence-guided encapsulation strategies to ensure the stoichiometric occupancy and structural stability required for clinical-grade manufacturing

Those are marketing summaries, not trial endpoints, and they list far more conditions than the evidence supports

What Is Cerebrolysin

Huan et al., 2020